Page last updated: 2024-10-25

ciclopirox and Cell Transformation, Neoplastic

ciclopirox has been researched along with Cell Transformation, Neoplastic in 1 studies

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research Excerpts

ExcerptRelevanceReference
"Ewing sarcoma is a highly aggressive bone and soft tissue cancer that is caused by the EWS-FLI1 fusion protein."1.43Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma. ( Gordon, DJ; Goss, KL, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goss, KL1
Gordon, DJ1

Other Studies

1 other study available for ciclopirox and Cell Transformation, Neoplastic

ArticleYear
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
    Oncotarget, 2016, Sep-27, Volume: 7, Issue:39

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Ciclopirox; Cl

2016